23andMe Holding Co (ME)
4.05
+0.09
(+2.27%)
USD |
NASDAQ |
Jan 08, 16:00
4.08
+0.03
(+0.74%)
After-Hours: 20:00
23andMe Research and Development Expense (Annual): 205.36M for March 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
RadNet Inc | -- |
iSpecimen Inc | 3.567M |
Natera Inc | 320.68M |
Progyny Inc | -- |
Delcath Systems Inc | 17.50M |